Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Breast 1

Conditions

Ovarian Neoplasms 39Breast Neoplasms 24Neoplasms 12Prostatic Neoplasms 11Triple Negative Breast Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 7Pancreatic Neoplasms 7Neoplasm Metastasis 7Carcinoma, Ovarian Epithelial 6Stomach Neoplasms 5Metastatic Castration-resistant Prostate Cancer 5Fanconi Anemia, Complementation Group D1 5Small Cell Lung Carcinoma 4Carcinoma, Non-Small-Cell Lung 4Advanced Solid Tumors 4Solid Tumors 3Fallopian Tube Neoplasms 3Endometrial Neoplasms 3Prostatic Neoplasms, Castration-Resistant 2Colorectal Neoplasms 2Carcinoma 2Advanced Solid Tumours 2Advanced Solid Tumor 2Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Metastatic Breast Cancer 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Diseases 1Platinum-sensitive Ovarian Cancer 1Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1

Interventions

Fulvestrant 9Alpelisib 6Letrozole 4serabelisib 3ribociclib 3palbociclib 3duvelisib 3berzosertib 3Paclitaxel 3PX-866 3Cetuximab 3sapanisertib 2pembrolizumab 2parsaclisib 2binimetinib 2Topotecan 2NVP-BKM120 2Irinotecan 2Gemcitabine 2venetoclax 1tipifarnib 1talazoparib 1sotorasib 1ruxolitinib 1olaparib 1obinutuzumab 1niraparib 1lorlatinib 1liposomal doxorubicin 1gedatolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Hereditary Sensory and Autonomic Neuropathies × olaparib × Clear all
NCT04586335 2024-03-21

Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.

Haihe Biopharma Co., Ltd.

Phase 1 Terminated
24 enrolled
BreastGenitourinaryGynecologic

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡